Nova Patents
MA51206A

Processes for making modulators of cystic fibrosis transmembrane conductance regulator

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

36 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
17382829European Patent Office (EPO)A
17382829European Patent Office (EPO)A
17382829–––
EP20170382829–––

Members36

Family members, oldest first
DocumentOfficeKind
CA3082444A1CanadaA1
WO2019109021A1World Intellectual Property Organization (WIPO)A1
AU2018375186A1AustraliaA1
SG11202004264VASingaporeA
IL274763AIsraelA
IL274763D0IsraelD0
CN111479804AChinaA
KR20200096560ARepublic of KoreaA
US2020290972A1United States of AmericaA1
EP3717455A1European Patent Office (EPO)A1
MA51206AThis recordMoroccoA
BR112020010335A2BrazilA2
AU2018375186B2AustraliaB2
US11708331B2United States of AmericaB2
IL274763B1IsraelB1
IL305169AIsraelA
AU2023248117A1AustraliaA1
CN111479804BChinaB
IL274763B2IsraelB2
CN117924170AChinaA
US2024166607A1United States of AmericaA1
US12024491B2United States of AmericaB2
KR102720000B1Republic of KoreaB1
KR20240153418ARepublic of KoreaA
EP3717455B1European Patent Office (EPO)B1
EP3717455C0European Patent Office (EPO)C0
EP4484402A2European Patent Office (EPO)A2
HRP20241608T1CroatiaT1
KR102768380B1Republic of KoreaB1
IL305169B1IsraelB1
ES3003533T3SpainT3
PL3717455T3PolandT3
HUE069984T2HungaryT2
IL305169B2IsraelB2
EP4484402A3European Patent Office (EPO)A3
AU2023248117B2AustraliaB2